Cleveland BioLabs Inc. | Mutual Funds
Mutual Funds that own Cleveland BioLabs Inc.
Vanguard Total Stock Market Index Fund
155,269
1.37%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
13,546
0.12%
0
0%
07/31/2018
iShares Micro Cap ETF
13,265
0.12%
0
0%
09/06/2018
Fidelity Spartan Extended Market Index Fund
10,000
0.09%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
4,912
0.04%
0
0%
07/31/2018
BlackRock Master Extended Market Index Series
2,800
0.03%
0
0%
01/31/2018
Fidelity Spartan Total Market Index Fund
1,776
0.02%
0
0%
07/31/2018
Vanguard Invt. Fds. ICVC - US Equity Index Fund
1,532
0.01%
0
0%
06/30/2018
1,274
0.01%
0
0.01%
09/05/2018
AXA/Lord Abbett Micro Cap Portfolio
775
0.01%
0
0%
03/31/2018
| Address |
73 High Street
Buffalo New York 14203
United States
|
|
Employees
|
- |
| Website |
http://www.cbiolabs.com |
| Updated |
07/08/2019 |
| Cleveland BioLabs, Inc. is a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. |
